APA (7th ed.) Citation

Kayser, S., Sartor, C., Giglio, F., Bruno, A., Webster, J., Chiusolo, P., . . . Papayannidis, C. (2024). Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease. Haematologica, 109(5), . https://doi.org/10.3324/haematol.2023.284310

Chicago Style (17th ed.) Citation

Kayser, Sabine, et al. "Impact of Inotuzumab Ozogamicin on Outcome in Relapsed or Refractory Acute B-cell Lymphoblastic Leukemia Patients Prior to Allogeneic Hematopoietic Stem Cell Transplantation and Risk of Sinusoidal Obstruction Syndrome/venous Occlusive Disease." Haematologica 109, no. 5 (2024). https://doi.org/10.3324/haematol.2023.284310.

MLA (9th ed.) Citation

Kayser, Sabine, et al. "Impact of Inotuzumab Ozogamicin on Outcome in Relapsed or Refractory Acute B-cell Lymphoblastic Leukemia Patients Prior to Allogeneic Hematopoietic Stem Cell Transplantation and Risk of Sinusoidal Obstruction Syndrome/venous Occlusive Disease." Haematologica, vol. 109, no. 5, 2024, https://doi.org/10.3324/haematol.2023.284310.